Corrêa et al. Critical Care (2015) 19:98 DOI 10.1186/s13054-015-0802-3

REVIEW Angiotensin II in septic shock Thiago D Corrêa1, Jukka Takala2,3 and Stephan M Jakob2,3*

The -angiotensin system Abstract Since the discovery of renin by Robert Tigerstedt and This article is one of ten reviews selected from the Per Gunnar Bergman in 1898, a lot of progress has been Annual Update in Intensive Care and Emergency made towards better understanding of the role of the Medicine 2015 and co-published as a series in Critical RAS in body and in disease. The classical Care. Other articles in the series can be found online circulating RAS includes angiotensinogen (the precursor at http://ccforum.com/series/annualupdate2015. of angiotensin), the enzymes renin and angiotensin con- Further information about the Annual Update in verting enzyme (ACE), which produces the bioactive Intensive Care and Emergency Medicine is available angiotensin II, and its receptors, AT-1 and AT-2. Aldos- from http://www.springer.com/series/8901. terone is often considered together with the circulating RAS, then referred to as the RAAS (renin-angiotensin- aldosterone system). The major components of the clas- Introduction sical ‘circulating’ RAS were described at the beginning of Systemic vasodilatation and arterial hypotension are the 1970s. In the subsequent decades, knowledge about landmarks of septic shock. Whenever fluid resuscitation angiotensin receptors and the complex interaction be- fails to restore arterial and tissue perfu- tween the RAS and other neuroendocrine pathways has sion, vasopressors agents are necessary [1]. Norepineph- increased [5]. One of the most remarkable advances has α rine, a strong -adrenergic agonist, is the standard been the discovery of a tissue (or local) RAS, and more vasopressor to treat septic shock-induced hypotension recently, the discovery of an intracellular RAS [8]. [1]. Adrenergic vasopressors have been associated with The local RAS contains all the components of the cir- several detrimental effects, including organ dysfunction culating RAS and exerts different functions in different and increased mortality [2,3]. Therefore, alternative organs. The local RAS has been identified in heart, agents have been proposed, yet with disappointing re- brain, , pancreas, and lymphatic and adipose tis- sults so far [4]. sues. It can operate independently, as in the brain, or in The renin-angiotensin system (RAS) provides an im- close connection with the circulating RAS, as in the kid- portant physiologic mechanism to prevent systemic neys and the heart [5]. While the circulating RAS is hypotension under hypovolemic conditions, such as mainly responsible for blood pressure control and fluid unresuscitated septic shock [5]. In addition to its clas- and electrolyte homeostasis, the local RAS is predomin- sical hemodynamic function of regulating arterial blood antly related to inflammatory processes, modulating vas- pressure, angiotensin II plays a key role in several bio- cular permeability, apoptosis, cellular growth, migration logical processes, including cell growth, apoptosis, in- and differentiation [6]. flammatory response, and coagulation. It may also affect mitochondrial function [6,7]. This review briefly discusses the main physiological Agiontensin II production functions of the RAS, and presents recent evidence sug- Juxtaglomerular cells of the renal afferent arteriole are gesting a role for exogenous angiotensin II administra- responsible for renin synthesis. Renin, a proteolytic en- tion as a vasopressor in septic shock. zyme, is stored as an inactive form, called pro-renin. Extracellular fluid volume depletion and/or decreased arterial blood pressure trigger several enzymatic reac- * Correspondence: [email protected] tions resulting in the release of active renin into sur- 2 Department of Intensive Care Medicine, Bern University Hospital, Inselspital, rounding tissues and the systemic circulation. However, Bern, Switzerland 3University of Bern, Bern, Switzerland renin has no hemodynamic effects (Figure 1) [8]. Full list of author information is available at the end of the article

© 2015 Springer-Verlag and BioMed Central. This article is co-published by agreement with Springer-Verlag. Permission for reuse must be sought from the publisher. Corrêa et al. Critical Care (2015) 19:98 Page 2 of 6

Figure 1 Overview of the renin-angiotensin system. MAP: mean arterial blood pressure; AT: angiotensin; ACE: angiotensin-converting enzyme; AMPA: aminopeptidase A; AMPM: aminopeptidase M; *: ACE is present mainly in lung capillaries, although it can also be found in the plasma and vascular beds of other organs, such as the kidneys, brain, heart and skeletal muscle.

Angiotensin I, a decapeptide with weak biological ac- Angiotensin II receptors tivity, is produced from angiotensinogen, an α2-globulin The physiological effects of angiotensin II result from its produced primarily in the liver and, to a lesser extent, in binding to specific G protein-coupled receptors. So far, the kidneys and other organs. Angiotensin is rapidly four angiotensin receptors have been described: AT-1, converted to angiotensin II by an ACE and, to a lesser AT-2, AT-4 and Mas [11]. Additionally, two isoforms of extent, by other chymases stored in secretory granules of AT-1 receptors (AT-1a and AT-1b) have been identified mast cells. Angiotensin II, an octapeptide, has strong in rodents [12,13]. It has been postulated that human vasopressor activity [8]. cells express only AT-1a receptors, located in the kidneys, ACE is present mainly in lung capillaries, although it vascular smooth muscle, heart, brain, adrenals, pituitary can also be found in the plasma and vascular beds of gland, liver and several other organs and tissues [11]. other organs, such as the kidneys, brain, heart and skel- The major physiological activities of angiotensin II are etal muscle. The action of angiotensin II is terminated mediated by AT-1 receptors. Thereby, angiotensin II acts by its rapid degradation into angiotensin 2–8 heptapep- to control arterial blood pressure, aldosterone release by tide (angiotensin III) and ultimately into angiotensin 3–8 the adrenal zona glomerulosa, sodium and water re- heptapeptide (angiotensin IV) by aminopeptidases A and absorption in the proximal tubular cells, and vasopressin M, respectively [8]. ACE-2 is a carboxypeptidase respon- secretion (Figure 1) [14]. When chronically stimulated, sible for the production of angiotensin 1–9 from angio- AT-1 receptors have been shown to mediate cardiac tensin I and angiotensin 1–7 from angiotensin II [9,10]. hypertrophy and induce cardiac remodeling [15]. Angiotensin 1–7 is a heptapeptide, which produces The function of AT-2 receptors in adults has not been vasodilatation mediated by its interaction with the completely determined and some authors suggest that prostaglandin-bradykinin-nitric oxide system [10]. their stimulation might counteract the AT-1 effects on The balance between ACE and ACE-2 may play an im- blood pressure regulation, inflammation and cell growth portant role in cardiovascular pathophysiology by modu- [11]. Indeed, angiotensin II binding to AT-2 receptors lating and controlling angiotensin II blood concentrations. results in vasodilatation and decreased systemic vascular The RAS is primary regulated by a negative feedback ef- resistance (Figure 1) [5]. fect of angiotensin II on renin production by the juxtaglo- A large number of experimental studies have shown merular cells of the renal afferent arteriole [5]. that angiotensin II mediates countless key elements of Corrêa et al. Critical Care (2015) 19:98 Page 3 of 6

inflammatory processes [6] (Figure 2). By binding to AT-1 volume and arterial blood pressure restoration in septic receptors, angiotensin II enhances the expression of pro- shock [32]. These mechanisms are sympathetic nervous inflammatory mediators, increases vascular permeability system activation, the release of arginine vasopressin by by inducing vascular endothelial growth factor (VEGF), the posterior pituitary gland, inhibition of atrial and cere- and stimulates the expression of endothelial adhesion bral natriuretic peptide secretion from the atria of the molecules (P-selectin and E-selectin), intercellular adhe- heart, and the increase in renin secretion by the juxtaglo- sion molecule-1 (ICAM-1) and vascular cell adhesion merular cells, resulting in elevated angiotensin II plasma molecule-1 (VCAM-1) (Figure 2) [6]. Angiotensin II also levels and an increased secretion of aldosterone from the promotes reactive oxygen species (ROS) production, cell adrenal cortex [32]. growth, apoptosis, angiogenesis, endothelial dysfunction, During sepsis, the activity of plasma renin, angiotensin cell migration and differentiation, leukocyte rolling, adhe- I and angiotensin II are increased [19]. Despite the high sion and migration, extracellular matrix remodeling. Fi- angiotensin II plasma levels, pronounced hypotension, nally, it can play a role in multiple intracellular signaling associated with a reduced vasopressor effect of angioten- pathways leading to organ and mitochondrial injury [16]. sin II, has been reported [17]. Moreover, RAS activation contributes to oxidative stress and endothelial dysfunc- The renin-angiotensin system in sepsis tion [24], which has been associated with development Activation of the RAS during sepsis is a well know of kidney [33] and pulmonary [25,26] injury and with phenomenon, observed in experimental [17] and clinical the severity of organ dysfunction [19]. studies [18-20]. However, so far, most of our knowledge Data from experimental animal models have suggested about the RAS system during septic shock has come that sepsis can induce a systemic downregulation of from a few experimental studies performed with healthy both AT-1 [21] and AT-2 receptors [22]. Proinflamma- rodents [17,21-26], sheep [27,28] or pigs [7]. The role of tory cytokines, e.g., interleukin (IL)-1β, tumor necrosis exogenous angiotensin II administration or its inhibition factor (TNF)-α, interferon (IFN)γ and nitric oxide (NO), in sepsis is poorly understood [29]. released during Gram-positive and Gram-negative sep- Unresuscitated septic shock is characterized by marked sis, downregulate AT-1 receptor expression. This leads hypovolemia, extracellular fluid volume depletion, de- to systemic hypotension and low aldosterone secretion creased cardiac output, low arterial blood pressure and de- despite increased plasma renin activity and angiotensin- creased systemic vascular resistance [30]. Septic shock II levels [21,22]. Very recently, it has been demonstrated triggers a complex neuro-humoral response, releasing sev- that sepsis down-regulates the expression of an AT-1 eral vasoactive substances in the circulation [31]. Four receptor-associated protein (Arap1), which contributes main mechanisms are involved in effective circulating to the development of hypotension secondary to reduced

Figure 2 Key potential mechanism attributed to angiotensin II’s action via AT-1 receptors. AT-1: angiotensin receptor 1; VEGF: vascular endothelial growth factor; ICAM-1: intercellular adhesion molecule-1; VCAM-1: vascular cell adhesion molecule-1; IL: interleukin; MIP-1α: macrophage inflammatory protein-1α; MCP-1: monocyte chemotactic protein-1; AP-1: activating protein-1; NF-κB: nuclear factor-kappa B; MAPK: mitogen-activated protein kinase. Corrêa et al. Critical Care (2015) 19:98 Page 4 of 6

vascular sensitivity to angiotensin II [23]. Downregula- Our data demonstrate that the effects of angiotensin II tion of adrenal AT-2 receptors may impair catechol- on regional perfusion are different in vasodilatatory amine release by the adrenal medulla and, thereby, play states compared to normal conditions: in healthy pigs, a critical role in the pathogenesis of sepsis-induced angiotensin II infusion resulted in net reduction of renal hypotension [22]. Mediators of the RAS have also been blood flow, while portal blood flow decreased in parallel associated with microvascular dysfunction in patients with cardiac output, and fractional blood flow increased with severe sepsis and septic shock [19]. dose-dependently in carotid, hepatic and femoral arteries [38]. As in sepsis, angiotensin II infusion had no effects Infusion of angiotensin II in septic shock on diuresis or creatinine clearance [38]. The discrepant Some early observations suggested that angiotensin II findings on renal perfusion can be explained by sepsis- may be used as an alternative vasopressor in cases of induced hyporeactivity of the renal arteries [39]. It seems, norepinephrine unresponsive septic shock [34-36]. The therefore, that organ perfusion is not at risk in experimen- main concern about exogenous administration of angio- tal septic shock treated with angiotensin II. tensin II in septic shock is related to its strong vasocon- Currently, a few studies are recruiting septic patients for strictor effect, which may impair regional blood flow evaluation of the effects of angiotensin II as a vasopressor and aggravate tissue perfusion. Angiotensin II binding to (Clinicaltrials.gov: NCT00711789 and NCT01393782). AT-1 receptors causes dose-dependent vasoconstriction of both afferent and efferent glomerular arterioles. In- Angiotensin II and mitochondrial function deed, the most pronounced effect of angiotensin II oc- In sepsis, mitochondrial dysfunction occurs, but its rele- curs on efferent arterioles [37], resulting in reduced vance in the development of organ failure is unclear renal blood flow and increased glomerular filtration [40]. Angiotensin II itself can stimulate mitochondrial pressure [27]. ROS production in endothelial cells [41] and alter car- Wan et al. demonstrated in a hyperdynamic sepsis diac mitochondrial electron transport chains [15]. model in conscious sheep that a six-hour infusion of Evidence has indicated a direct interaction between angiotensin II was effective in restoring arterial blood angiotensin II and mitochondrial components [42-45]. pressure and increased urinary output and creatinine In a study using 125 I-labeled angiotensin II in rats, clearance, despite a marked decrease in renal blood flow angiotensin II was detected in the mitochondria and nu- [27]. In this study, mesenteric, coronary and iliac artery clei of the heart, brain and smooth muscle cells [42,43]. blood flow were also affected but to a lesser degree [27]. In rat adrenal zona glomerulosa, renin, angiotensinogen In a similar model in anesthetized sheep, the same group and ACE were detected within intramitochondrial dense reported an equal decrease in renal blood flow in controls bodies [44], and renin has been detected in the cytosol and angiotensin II treated animals, but renal conductance of cardiomyocyte cell lines [45]. However, we recently was lower in angiotensin II-treated animals [28]. demonstrated that high-affinity angiotensin II binding We recently evaluated in pigs the long term effects of sites are actually located in the mitochondria-associated exogenous angiotensin II administration on systemic membrane fraction of rat liver cells, but not in purified and regional hemodynamics, tissue perfusion, inflamma- mitochondria [46]. Moreover, we found that angiotensin tory response, coagulation and mitochondrial function II had no effect on the function of isolated mitochondria [7]. In this study, 16 pigs were randomized to receive ei- at physiologically relevant concentrations [46]. It, there- ther norepinephrine or angiotensin II for 48 hours after fore, seems unlikely that the effects of angiotensin II on a 12-hour period of untreated sepsis. An additional cellular energy metabolism are mediated through its dir- group was pre-treated with enalapril (20 mg/d orally) for ect binding to mitochondrial targets. one week prior to the experiment, and then with intra- In septic pigs, a 48-hour angiotensin II infusion did venous enalapril (0.02 mg/kg/h) until the end of the not affect kidney, heart or liver mitochondrial respir- study. We found that angiotensin II was as effective as ation in comparison to norepinephrine-treated animals norepinephrine to restore arterial blood pressure, and [7]. Although other mitochondrial functions, such as cardiac output increased similarly as in animals resusci- ROS production or enzymatic activity, were not assessed tated with norepinephrine. Renal plasma flow, incidence in this study, it seems unlikely that angiotensin II dimin- of acute kidney injury, inflammation and coagulation ishes oxygen consumption in sepsis. patterns did not differ between the two groups [7]. How- ever, enalapril-treated animals did not achieve the blood Conclusion pressure targets despite receiving high norepinephrine The RAS plays a key role in fluid and electrolyte homeo- doses (approximately 2.0 mcg/kg/min), and they had a stasis, arterial blood pressure and blood flow regulation. higher incidence of acute kidney injury at the end of the A better understanding of its complex interactions with study [7]. other neuroendocrine regulating systems is crucial for Corrêa et al. Critical Care (2015) 19:98 Page 5 of 6

the development of new therapeutic options to treat sep- 14. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin tic shock. Angiotensin II is a powerful vasopressor in ex- system – an endocrine and paracrine system. Endocrinology. 2003;144:2179–83. perimental septic shock, and has proved to be safe in the 15. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, Quackenbush J. Cardiac tested settings. Administration of angiotensin II as an al- transcriptional response to acute and chronic angiotensin II treatments. ternative to norepinephrine should be further evaluated Physiol Genomics. 2004;18:152–66. 16. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in in clinical trials. inflammation, immunology and aging. EMBO Mol Med. 2010;2:247–57. 17. Schaller MD, Waeber B, Nussberger J, Brunner HR. Angiotensin II, Abbreviations vasopressin, and sympathetic activity in conscious rats with endotoxemia. AMPA: Aminopeptidase A; AMPM: Aminopeptidase M; AP-1: Activating Am J Physiol. 1985;249:H1086–92. protein-1; ARAP1: AT-1 receptor-associated protein; AT: Angiotensin; 18. Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bonmarchand AT-1: Angiotensin receptor 1; ICAM-1: Intercellular adhesion molecule-1; G. Erythropoietin and renin as biological markers in critically ill patients. Crit IL: Interleukin; MAP: Mean arterial blood pressure; MAPK: Mitogen-activated Care. 2004;R328–R335 protein kinase; MCP-1: Monocyte chemotactic protein-1; MIP-1α: Macrophage 19. Doerschug KC, Delsing AS, Schmidt GA, Ashare A. Renin-angiotensin system inflammatory protein-1α; NF-κB: Nuclear factor-kappa B; NO: Nitric oxide; activation correlates with microvascular dysfunction in a prospective cohort RAAS: Renin-angiotensin-aldosterone system; RAS: Renin-angiotensin system; study of clinical sepsis. Crit Care. 2010;14:R24. ROS: Reactive oxygen species; TNF: Tumor necrosis factor; VCAM-1: Vascular 20. Hilgenfeldt U, Kienapfel G, Kellermann W, Schott R, Schmidt M. Renin- cell adhesion molecule-1; VEGF: Vascular endothelial growth factor. angiotensin system in sepsis. Clin Exp Hypertens A. 1987;9:1493–504. 21. Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension. 2001;38:177–82. Competing interests 22. Bucher M, Hobbhahn J, Kurtz A. Nitric oxide-dependent down-regulation of The authors declare that they have no competing interests. angiotensin II type 2 receptors during experimental sepsis. Crit Care Med. 2001;29:1750–5. Declarations 23. Mederle K, Schweda F, Kattler V, et al. The angiotensin II AT1 receptor- Publication of this article was funded by SNF (Swiss National Science associated protein Arap1 is involved in sepsis-induced hypotension. Crit Foundation), grant no. 32003B_127619/1. Care. 2013;17:R130. 24. Lund DD, Brooks RM, Faraci FM, Heistad DD. Role of angiotensin II in Author details endothelial dysfunction induced by lipopolysaccharide in mice. Am J 1Hospital Israelita Albert Einstein, Intensive Care Unit, São Paulo, Brazil. Physiol Heart Circ Physiol. 2007;293:H3726–31. 2Department of Intensive Care Medicine, Bern University Hospital, Inselspital, 25. Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from Bern, Switzerland. 3University of Bern, Bern, Switzerland. severe acute lung failure. Nature. 2005;436:112–6. 26. Klein N, Gembardt F, Supe S, et al. Angiotensin-(1–7) protects from experimental acute lung injury. Crit Care Med. 2013;41:e334–43. 27. Wan L, Langenberg C, Bellomo R, May CN. Angiotensin II in experimental hyperdynamic sepsis. Crit Care. 2009;13:R190. References 28. May CN, Ishikawa K, Wan L, et al. Renal bioenergetics during early gram- 1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: negative mammalian sepsis and angiotensin II infusion. Intensive Care Med. – international guidelines for management of severe sepsis and septic shock. 2012;38:886 93. Crit Care Med. 2012;41:580–637. 29. Salgado DR, Rocco JR, Silva E, Vincent JL. Modulation of the renin- 2. Dunser MW, Ruokonen E, Pettila V, et al. Association of arterial blood angiotensin-aldosterone system in sepsis: a new therapeutic approach? – pressure and vasopressor load with septic shock mortality: a post hoc Expert Opin Ther Targets. 2010;14:11 20. analysis of a multicenter trial. Crit Care. 2009;13:R181. 30. Correa TD, Vuda M, Blaser AR, et al. Effect of treatment delay on disease 3. De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus severity and need for resuscitation in porcine fecal peritonitis. Crit Care – norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med. 2012;40:2841 9. Med. 2012;40:725–30. 31. Cuesta JM, Singer M. The stress response and critical illness: a review. Crit – 4. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine Care Med. 2012;40:3283 9. infusion in patients with septic shock. N Engl J Med. 2008;358:877–87. 32. Rolih CA, Ober KP. The endocrine response to critical illness. Med Clin North 5. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. Am. 1995;79:211–24. 2008;264:224–36. 33. du Cheyron D, Lesage A, Daubin C, Ramakers M, Charbonneau P. 6. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Hyperreninemic hypoaldosteronism: a possible etiological factor of septic Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35:881–900. shock-induced acute renal failure. Intensive Care Med. 2003;29:1703–9. 7. Correa TD, Jeger V, Pereira AJ, Takala J, Djafarzadeh S, Jakob SM. 34. Thomas VL, Nielsen MS. Administration of angiotensin II in refractory septic Angiotensin II in septic shock: effects on tissue perfusion, organ function, shock. Crit Care Med. 1991;19:1084–6. and mitochondrial respiration in a porcine model of fecal peritonitis. Crit 35. Wray GM, Coakley JH. Severe septic shock unresponsive to noradrenaline. Care Med. 2014;42:e550–9. Lancet. 1995;346:1604. 8. Paul M, Poyan MA, Kreutz R. Physiology of local renin-angiotensin systems. 36. Yunge M, Petros A. Angiotensin for septic shock unresponsive to Physiol Rev. 2006;86:747–803. noradrenaline. Arch Dis Child. 2000;82:388–9. 9. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting 37. Denton KM, Anderson WP, Sinniah R. Effects of angiotensin II on regional enzyme-related carboxypeptidase (ACE2) converts angiotensin I to afferent and efferent arteriole dimensions and the glomerular pole. Am J angiotensin 1–9. Circ Res. 2000;87:E1–9. Physiol Regul Integr Comp Physiol. 2000;279:R629–38. 10. Santos RA, Ferreira AJ. Angiotensin-(1–7) and the renin-angiotensin system. 38. Pereira AJ, Jeger V, Fahrner R, et al. Interference of angiotensin II and Curr Opin Nephrol Hypertens. 2007;16:122–8. enalapril with hepatic blood flow regulation. Am J Physiol Gastrointest Liver 11. Zhuo JL, Li XC. New insights and perspectives on intrarenal renin- Physiol. 2014;307:G655–663. angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides. 39. Yu HP, Hsu JC, Yen CH, Ma YH, Lau YT. Hyporeactivity of renal artery to 2011;32:1551–65. angiotensin II in septic rats. Chin J Physiol. 2008;51:301–7. 12. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ. Cloning, 40. Jeger V, Djafarzadeh S, Jakob SM, Takala J. Mitochondrial function in sepsis. characterization, and expression of two angiotensin receptor (AT-1) isoforms Eur J Clin Invest. 2013;43:532–42. from the mouse genome. Biochem Biophys Res Commun. 1992;185:253–9. 41. Kimura S, Zhang GX, Nishiyama A, et al. Mitochondria-derived reactive 13. Iwai N, Inagami T. Identification of two subtypes in the rat type I oxygen species and vascular MAP kinases: comparison of angiotensin II and angiotensin II receptor. FEBS Lett. 1992;298:257–60. diazoxide. Hypertension. 2005;45:438–44. Corrêa et al. Critical Care (2015) 19:98 Page 6 of 6

42. Robertson Jr AL, Khairallah PA. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science. 1971;172:1138–9. 43. Sirett NE, McLean AS, Bray JJ, Hubbard JI. Distribution of angiotensin II receptors in rat brain. Brain Res. 1977;122:299–312. 44. Peters J, Kranzlin B, Schaeffer S, et al. Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex. Am J Physiol. 1996;271:E439–50. 45. Wanka H, Kessler N, Ellmer J, et al. Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts. J Cell Mol Med. 2009;13:2926–37. 46. Astin R, Bentham R, Djafarzadeh S, et al. No evidence for a local renin- angiotensin system in liver mitochondria. Sci Rep. 2013;3:2467.